FindMyKOL
Clinical trialNCT01560780CompletedPhase 3Interventional

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

SponsorVA Office of Research and DevelopmentEnrollment84Coronary Artery Bypass
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a randomized-controlled clinical trial that will randomize 120 patients undergoing clinically-indicated coronary artery bypass graft surgery to prasugrel at a dose of 10 mg daily or matching placebo for 12 months, starting at the time of hospital dismissal from surgery. The primary goal of the study is to determine whether prasugrel administration will prevent thrombus (clot) formation within a saphenous vein graft at 12 months, as examined by optical coherence tomography.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Shuaib M. Abdullah, MD

    VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • San Francisco Va Medical Center, San Francisco, Ca

    San Francisco, California, United States

  • North Florida/south Georgia Veterans Health System, Gainesville, Fl

    Gainesville, Florida, United States

  • Jesse Brown Va Medical Center Community-Based Outpatient Clinic Lake Side Divison, Chicago, Il

    Chicago, Illinois, United States

  • Va North Texas Health Care System Dallas Va Medical Center, Dallas, Tx

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Feb 2013
Primary completion
30 Apr 2018
Completion
31 May 2018
Last update posted
30 Oct 2019
Registered enrollment
84
Registry id
NCT01560780

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.